尽管股票跌至52周的最低点, 阿博特实验室报告了强的收益和提高预期. Abbott Laboratories reported strong earnings and raised guidance, despite stock hitting a 52-week low.

艾博特实验室的分析师反应不一, 高盛降低了目标, 而其他公司则保持积极看法. Abbott Laboratories saw a mixed analyst response, with Goldman Sachs lowering its target while others maintained positive views. 尽管公司收入出现一些不足,但该公司报告了强的收益并提高了2026年的预期. The company reported strong earnings and raised its 2026 guidance, despite some revenue shortfalls. 尽管分析师预计股价可能会上. The stock recently hit a 52-week low, though analysts project a potential upside.